iShares Health Innovation Active ETF BMED

Medalist Rating as of | See BlackRock Investment Hub

Morningstar’s Analysis BMED

Will BMED outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

iShares Health Innovation Active ETF holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BMED

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 42.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Gilead Sciences Inc

5.65 798,687
Healthcare

BlackRock Cash Funds Treasury SL Agency

5.59 790,000
Cash and Equivalents

Danaher Corp

5.33 752,959
Healthcare

AbbVie Inc

4.93 697,065
Healthcare

Moderna Inc

4.89 691,203
Healthcare

Thermo Fisher Scientific Inc

4.37 617,771
Healthcare

Biogen Inc

3.84 542,359
Healthcare

IQVIA Holdings Inc

3.72 526,133
Healthcare

Mettler-Toledo International Inc

3.59 507,564
Healthcare

Vertex Pharmaceuticals Inc

3.24 457,461
Healthcare

Sponsor Center